Cardiothoracic & vascular anesthesia
Cardiac Surgery in Jehovah's Witnesses: 329 Consecutive Cases
Authors' conclusion
This study demonstrated that cardiac surgery in JWs is safe when adhering to a strict perioperative patient blood management protocol.
Study context
- Population
- Jehovah's Witnesses undergoing cardiac surgery at a cardiovascular centre with tertiary intensive care unit (ICU) (Amphia Hospital), Jan 2001–Jan 2022
- Participants
- 329 participants
- Outcome
- Outcome of JWs undergoing cardiac surgery
Methodological detailssingle-centre, Institutional perioperative care protocol for Jehovah's Witnesses (JWs) applied for 21 years
- Single-centre
- Institutional perioperative care protocol for JWs applied for 21 years
Main finding
As reported in the abstract
- Hospital mortality (related to cardiac failure)
- 0.6%
- Mean preoperative hemoglobin, g/dL (range 9.8-18.5)
- 14.5
- Mean hemoglobin at hospital discharge, g/dL (range 6.6-15.6)
- 11.6
- Mean blood loss first 12 h postsurgery, mL (± 349)
- 439
- Maximum mean postoperative troponin, ng/L (± 424)
- 431
- Resternotomy
- 3.6%
- Postoperative MI
- 4.2%
- ICU stay, days (± 1.8)
- 1.4
- Hospital stay, days (± 4.2)
- 6.8
Observational data: associations, not effects.
Further findings
Baseline and procedures
- Treated preoperatively for anemia (23 patients)
- 6.8%
- Mean EuroSCORE (range 0-18)
- 5.1
- CABG
- 53.2%
- Aortic valve replacement
- 13.4%
Original publication
Cardiac Surgery in Jehovah's Witnesses: 329 Consecutive Cases. J Cardiothorac Vasc Anesth. Published 7 April 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →